Comparison | Number of units | SMD (95% Cl) | I2 | Â |
---|---|---|---|---|
Types of NIBS | Â | Â | Â | |
 tDCS | 12 | -0.214 (-0.427 to -0.002)* | 15.4% | |
 TMS | 10 | -0.202 (-0.489 to 0.086) | 36.1% | |
Site of stimulation | Â | Â | Â | |
 dlPFC | 17 | -0.200 (-0.381 to -0.019)* | 13.0% | |
 Other sites | 5 | -0.229 (-0.687 to 0.230) | 53.4% | |
Number of sessions | Â | Â | Â | |
 Single-session | 11 | -0.020 (-0.206 to 0.166) | 0.0% | |
 Multiple sessions | 11 | -0.388 (-0.620 to -0.156)* | 12.5% | |
Time point of craving assessment | Â | Â | Â | |
 After stimulation | 18 | -0.126 (-0.291 to 0.038) | 0.0% | |
 Follow up for at least 4 weeks | 4 | -0.553 (-0.979 to -0.126)* | 35.1% | |
Study design | Â | Â | Â | |
 Parallel or factorial design | 16 | -0.311 (-0.520 to -0.101)* | 19.6% | |
 Cross-over design | 6 | 0.007 (-0.209 to 0.224) | 0.0% | |
Quality assessment | Â | Â | Â | |
 Low risk of bias | 6 | -0.160 (-0.450 to 0.129) | 0.0% | |
 Unclear or high risk of bias | 16 | -0.233 (-0.443 to -0.023)* | 32.6% |